Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts
新型双特异性抗HER2抗体Zanidatamab在患者来源异种移植模型中的联合临床试验
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-23-0838
DiPeri, Timothy P; Evans, Kurt W; Wang, Bailiang; Zhao, Ming; Akcakanat, Argun; Raso, Maria Gabriela; Rizvi, Yasmeen Q; Zheng, Xiaofeng; Korkut, Anil; Varadarajan, Kaushik; Uzunparmak, Burak; Dumbrava, Ecaterina E; Pant, Shubham; Ajani, Jaffer A; Pohlmann, Paula R; Jensen, V Behrana; Javle, Milind; Rodon, Jordi; Meric-Bernstam, Funda